Evidence map›Paper›PMID 34097506›Full record

ArticleInfection and immunity2021

Class B Scavenger Receptors BI and BII Protect against LPS-Induced Acute Lung Injury in Mice by Mediating LPS.

Irina N Baranova, Alexander V Bocharov, Tatyana G Vishnyakova, Zhigang Chen, Anna A Birukova, Yunbo Ke, Xuzhen Hu, Peter S T Yuen, Robert A Star, Konstantin G Birukov and 2 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Association betweenBiomedical reports · 2024
    Review
  5. Review
  6. Article
  7. Anti-inflammatory effect of ApoE23 onOpen medicine (Warsaw, Poland) · 2023
    Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Irina N BaranovaDepartment of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0003-4250-1340
Alexander V BocharovDepartment of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Tatyana G VishnyakovaDepartment of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Zhigang ChenDepartment of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Anna A BirukovaDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Yunbo KeDepartment of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Xuzhen HuRenal Diagnostics and Therapeutics Unit, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Peter S T YuenRenal Diagnostics and Therapeutics Unit, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Robert A StarRenal Diagnostics and Therapeutics Unit, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Konstantin G BirukovDepartment of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Amy P PattersonDepartment of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Thomas L EggermanDepartment of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
National Institutes of Health · USNational Institutes of Health Clinical Center · USUniversity of Maryland, Baltimore · US

Funding

Inhibition Of Renal InjuryZIADK043403 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI STAR, ROBERT A · 2009 to 2025
$15.5M
Early Detection Of Renal InjuryZIADK043400 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI STAR, ROBERT A · 2009 to 2025
$9.5M
Control of Lung Permeability by Oxidized PhospholipidsR01HL076259 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BIRUKOV, KONSTANTIN · 2004 to 2023
$6.8M
Molecular control of lung endothelial barrier function in ALIR01HL087823 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BIRUKOV, KONSTANTIN · 2008 to 2020
$4.6M
Microtubule-associated regulation of acute lung injuryR01HL107920 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BIRUKOVA, ANNA · 2011 to 2019
$2.8M
Control of septic inflammation and lung microvascular endothelial barrier by cell junction signaling nexusR01HL152761 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BIRUKOVA, ANNA · 2021 to 2024
$2.2M
Mechanisms of microvascular endothelial cell injury caused by extracellular histonesR01HL155051 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BIRUKOVA, ANNA · 2021 to 2024
$1.8M
Differential mechano-signaling in vascular endothelium by varying degrees of mechanical stretch - Resubmission 01R01HL130431 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BIRUKOVA, ANNA · 2016 to 2019
$1.6M
Modulation of inflammation in aging lungR01HL146829 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BIRUKOV, KONSTANTIN · 2020 to 2023
$1.5M
Microtubule control of septic inflammationR01GM114171 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI BIRUKOVA, ANNA · 2015 to 2018
$1.2M
Phospholipidomics and inflammation in sepsisR01GM122940 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI BIRUKOV, KONSTANTIN · 2017 to 2020
$1.2M
Microtubule-associated regulation of acute lung injuryR56HL107920 · NHLBI · UNIVERSITY OF CHICAGO · PI BIRUKOVA, ANNA · 2015 to 2015
$395k
NHLBI NIH HHS R01 HL076259NHLBI NIH HHS R01 HL087823NHLBI NIH HHS R01 HL107920NHLBI NIH HHS R01 HL130431NHLBI NIH HHS R01 HL146829NHLBI NIH HHS R01 HL152761NHLBI NIH HHS R01 HL155051NHLBI NIH HHS R56 HL107920NIGMS NIH HHS R01 GM114171NIGMS NIH HHS R01 GM122940
6 · The paper itself

Abstract

Recent studies suggest an anti-inflammatory protective role for class B scavenger receptor BI (SR-BI) in endotoxin-induced inflammation and sepsis. Other data, including ours, provide evidence for an alternative role of SR-BI, facilitating bacterial and endotoxin uptake and contributing to inflammation and bacterial infection. Enhanced endotoxin susceptibility of SR-BI-deficient mice due to their anti-inflammatory glucocorticoid deficiency complicates the understanding of SR-BI's role in endotoxemia/sepsis, calling for the use of alternative models. In this study, using human SR-BI (hSR-BI) and hSR-BII transgenic mice, we found that SR-BI and, to a lesser extent, its splicing variant SR-BII protect against LPS-induced lung damage. At 20 h after intratracheal LPS instillation, the extent of pulmonary inflammation and vascular leakage was significantly lower in hSR-BI and hSR-BII transgenic mice than in wild-type mice. Higher bronchoalveolar lavage fluid (BALF) inflammatory cell count and protein content and lung tissue neutrophil infiltration found in wild-type mice were associated with markedly (2 to 3 times) increased proinflammatory cytokine production compared to these parameters in transgenic mice following LPS administration. The markedly lower endotoxin levels detected in BALF of transgenic versus wild-type mice and the significantly increased BODIPY-LPS uptake observed in lungs of hSR-BI and hSR-BII mice 20 h after the i.t. LPS injection suggest that hSR-BI- and hSR-BII-mediated enhanced LPS clearance in the airways could represent the mechanism of their protective role against LPS-induced acute lung injury.

Indexed as

A549 CellsAcute Lung InjuryAnimalsBronchoalveolar Lavage FluidCell Line, TumorCytokinesDisease Models, AnimalEndotoxemiaHumansInflammationLipopolysaccharidesLysosomal Membrane ProteinsMaleMiceMice, Inbred C57BLMice, TransgenicCytokinesLipopolysaccharidesLysosomal Membrane ProteinsReceptors, ScavengerSCARB1 protein, humanScarb1 protein, mouseSCARB2 protein, humanScavenger Receptors, Class Bacute lung injuryclass B scavenger receptorsinflammationlipopolysaccharideLPSproinflammatory cytokinesSR-BISR-BII

Identifiers

PMID34097506
PMCPMC8445172
OpenAlexW3171180083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.